Tandem CGM integrationsLife is Better with Options
Choose Your Sensor
We know that choosing how to manage diabetes is a personal choice. That’s why we’ve been partnering with trusted CGM partners for more than a decade — so you can pick the sensor* that matches your lifestyle.
Dexcom CGM Sensors
Tandem Mobi system and t:slim X2 pump
FreeStyle Libre 3 Plus
t:slim X2 pump only
Even if your blood sugar is tested often, there could be a big part of the picture you’re not seeing with fingersticks alone. Learn more about how CGM integration with a Tandem pump can help you visualize trends.
An AID system is made up of an insulin pump, a CGM sensor, and a predictive algorithm — like Control-IQ+ technology — which can predict glucose levels and automatically deliver or suspend insulin.
What's next?
Whether you're ready to get a Tandem insulin pump, or looking to check insurance coverage, you’ll find everything you need here.
* CGM sold separately.
Important Safety Information
RX ONLY.
Indications for Use
Tandem Mobi system: The Tandem Mobi insulin pump with interoperable technology (the pump) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The Pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is indicated for use in persons 2 years of age and greater.
t:slim X2 insulin pump: The t:slim X2 insulin pump with interoperable technology (the pump) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is indicated for use in persons 2 years of age and greater.
Control-IQ+ technology: Control-IQ+ technology is intended for use with compatible integrated continuous glucose monitors (iCGM, sold separately) and alternate controller enabled (ACE) pumps to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. Control-IQ+ technology is intended for the management of type 1 diabetes mellitus in persons 2 years of age and greater and of type 2 diabetes mellitus in persons 18 years of age and greater.
Warning: Control-IQ+ technology should not be used in anyone under the age of 2 years old with type 1 diabetes or under the age of 18 years old with type 2 diabetes. It should also not be used in patients who require less than a total daily insulin dose of 5 units of insulin per day or who weigh less than 20 pounds (9 kilograms), as those are the required minimum values needed for Control-IQ+ to operate safely.
Users of the pump and Control-IQ+ must: use the insulin pump, iCGM, and all other system components in accordance with their respective instructions for use. Failure to follow these instructions for use could result in an over delivery or under delivery of insulin. This can cause hypoglycemia (low BG) or hyperglycemia (high BG) events. Visit tandemdiabetes.com/safetyinfo for additional important safety information.
FreeStyle Libre 3 Plus sensor: For FreeStyle Libre 3 Plus sensor safety information, please visit freestyle.abbott/us-en/safety-information. The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott and used with permission.